Patent application number | Description | Published |
20090155883 | Scientifically Modulated And Reprogrammed Treatment (SMART) Virus Technology Intended to Neutralize the Human Immunodeficiency Virus - The concept is to combat one of the deadliest infectious diseases known by fighting fire with fire. Scientifically Modulated And Reprogrammed Treatment (SMART) Virus technology is intended to neutralize the Human Immunodeficiency Virus. The SMART Virus carrying combinations of CD4, CCR5 and CXCR4 cell-surface receptors is capable of engaging the HIV's gp 120 and gp 41 exterior probes in an identical manner as would HIV's host, a T-Helper cell. When HIV encounters a SMART Virus the HIV virion would either adhere to the SMART Virus unable to further migrate in search of a T-Helper cell, harmlessly eject its RNA genetic payload or inject its RNA genome into the SMART Virus. Given HIV engaged a SMART Virus rather than a T-Helper cell, the HIV RNA genome becomes unable to infect a T-Helper cell, therefore the threat of Acquired Immunodeficiency Syndrome caused by HIV is averted. | 06-18-2009 |
20090169599 | SCIENTIFICALLY MODULATED AND REPROGRAMMED TREATMENT (SMART) FAS/FASL VIRUS TECHNOLOGY INTENDED TO NEUTRALIZE T-HELPER CELLS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS - Scientifically Modulated And Reprogrammed Treatment (SMART) Virus Fas/FasL technology is intended to terminate T-Helper cells infected with the Human Immunodeficiency Virus. The SMART-Fas/FasL Virus carrying Fas and FasL cell-surface receptors is capable of engaging a T-Helper cell infected by HIV that is expressing one or more FasL cell-surface receptors. When a T-Helper cell infected with HIV encounters a SMART-Fas/FasL Virus, the infected T-Helper cell's FasL cell-surface receptor will engage the SMART-Fas/FasL Virus's Fas receptor, then the SMART-Fas/FasL Virus's FasL will engage the infected T-Helper cell's Fas receptor, which will initiate apoptosis in the infected T-Helper cell. Given the HIV infected T-Helper cell will be triggered to die, HIV's safe haven inside the T-Helper cell will be eliminated and the threat of Acquired Immunodeficiency Syndrome caused by HIV is averted. | 07-02-2009 |
20090175831 | ADAPTABLE MESSENGER RIBONUCLEIC ACID MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS - Diabetes mellitus is a disease of elevated blood glucose, often directly related to a deficiency in insulin production or insulin receptor production. The innovative strategy of treatment described here utilizes modified viruses to act as a transport vehicle to deliver to target cells in the body, messenger RNA molecules. Delivering to the beta cells in the body the messenger RNA molecules needed to construct insulin or insulin receptors will lead to enhanced production of biologically active insulin or insulin receptors by beta cells as necessary, which will lead to correcting deficiencies in insulin or insulin receptors the result of which will help properly regulate blood glucose levels throughout the body utilizing innate regulatory mechanisms. | 07-09-2009 |
20090220542 | VACCINE COMPRISED SPECIFICALLY OF PROTEIN SUBUNITS OF HUMAN IMMUNODEFICIENCY VIRUS'S GLYCOPROTEIN 120 PROBE TO PREVENT AND TREAT AN INFECTION CAUSED BY THE HUMAN IMMUNODEFICIENCY VIRUS - The human immunodeficiency virus poses a significant threat to the health and well being of the world's population. Current strategies utilized to eradicate this deadly pathogen have not been effective. A vaccine comprised solely of protein subunits of the glycoprotein 120 probe as the active ingredient, can be effective in stimulating an individual's immune system to repel an HIV infection. The protein subunit of the glycoprotein 120 probe extends from the surface of HIV and is the unique identifier of an HIV virion. When protein subunits of HIV's glycoprotein probe are exclusively presented to the immune system, the antibodies generated will neutralize the glycoprotein 120 probes located on the surface of HIV virions, such that the virus's virions then are incapable of engaging a T-Helper cell and thus the infectious threat posed by HIV is averted. | 09-03-2009 |
20090246176 | METHOD FOR TREATING DIABETES MELLITUS, OBESITY, CHRONIC FATIGUE, AGING, AND OTHER MEDICAL CONDITIONS BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT MESSENGER RIBONUCLEIC ACID MOLECULES INTO CELLS - The common link between diabetes mellitus, obesity, chronic fatigue and even aging may be related to deficiencies involving a body's metabolism of glucose and the ability to optimally conduct the necessary biologic processes of aerobic respiration. Utilizing a modified form of virus to deliver to cells in the body the messenger RNA molecules needed to construct insulin receptors and generate the enzymes that participate in the processes of glycolysis, the tricarboxylic acid cycle, oxidative phosphorylation and anaerobic respiration will lead to greater utilization of blood glucose and a more efficient and sustained production of the energy molecules that fuel the metabolic processes of the cell. Greater utilization of blood glucose will correct problems associated with diabetes, obesity, chronic fatigue, and aging. | 10-01-2009 |
20090257982 | MEDICAL DEVICE FOR TREATING DIABETES MELLITUS, OBESITY, CHRONIC FATIGUE, AGING, AND OTHER MEDICAL CONDITIONS BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT MESSENGER RIBONUCLEIC ACID MOLECULES INTO CELLS - The common link between diabetes mellitus, obesity, chronic fatigue and even aging may be related to deficiencies involving a body's metabolism of glucose and the ability to optimally conduct the necessary biologic processes of aerobic respiration. Utilizing a medical device comprised of a modified form of virus to deliver to cells in the body the messenger RNA molecules needed to construct insulin receptors and generate the enzymes that participate in the processes of glycolysis, the tricarboxylic acid cycle, oxidative phosphorylation and anaerobic respiration will lead to greater utilization of blood glucose and a more efficient and sustained production of the energy molecules that fuel the metabolic processes of the cell. Greater utilization of blood glucose will significantly advance the effort to correct the medical problems associated with diabetes, obesity, chronic fatigue, and aging. | 10-15-2009 |
20090257983 | MEDICAL TREATMENT DEVICE FOR TREATING AIDS BY UTILIZING MODIFIED HUMAN IMMUNODEFICIENCY VIRUS VIRIONS TO INSERT ANTI-VIRAL MEDICATIONS INTO T-HELPER CELLS - The medical device by which a modified Human Immunodeficiency Virus or virus-like structure is used as a transport medium to carry a payload of a quantity of anti-viral drug molecules to T-Helper cells in the body. The modified Human Immunodeficiency Virus or virus-like structure makes contact with a T-Helper cell by means of the modified virus's exterior probes or virus-like structure's exterior probes. Once the exterior probes engage the T-Helper cell's receptors, the modified virus or virus-like structure inserts into the T-Helper cell the quantity of medically therapeutic anti-viral drug molecules it is carrying. The anti-viral drug molecules exhibit an anti-viral effect when present inside the T-Helper cells thus assisting in repelling an infection by the Human Immunodeficiency Virus and the use of such a device significantly lowers the occurrence of unwanted deleterious side effects. | 10-15-2009 |
20090257998 | METHOD FOR TREATING HEART ATTACKS, STROKES AND DIABETIC CRISIS BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT NECESSARY PROTEIN MOLECULES AND VITAL NUTRIENTS INTO TARGETED CELLS - The common link between incurring a heart attack, suffering a stroke or diabetic crisis is related to deficiencies involving a body's metabolism of glucose and the ability to optimally conduct the necessary biologic processes of aerobic respiration to produce energy molecules. Utilizing a medical treatment method comprised of a modified form of virus to deliver to cells in the body the protein molecules and nutrients needed to enhance the processes of glycolysis, the tricarboxylic acid cycle, oxidative phosphorylation and anaerobic respiration will save lives. Providing an alternative means for brain cells and heart muscle cells to have access to proteins, nutrients such as glucose and oxygen, and energy molecules by providing these tissues with viruses that carry these vital elements to these tissues will greatly improve the survivability of individuals experiencing a heart attack, a stroke or a diabetic crisis. | 10-15-2009 |
20090258879 | METHOD FOR TREATING CANCER, RHEUMATOID ARTHRITIS AND OTHER MEDICAL DISEASES BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT MEDICATIONS INTO TARGETED CELLS - A safer, more effective treatment of many medical diseases may be approached by a method utilizing modified viruses as vehicles to transport medically therapeutic drug molecules to specific cells in the body with the intent to have the drug exert an effect only on those cells to which the modified virus delivers the drug. The modified virus or virus-like structures make contact with specific target cells by means of the modified virus's exterior probes or virus-like structures' exterior probes. Once the exterior probes engage a target cell's receptors, the modified virus or virus-like structure inserts into the target cell the quantity of medically therapeutic drug molecules it is carrying. By delivering the medically therapeutic drug only to specific cells in the body it is assured the drug reaches the site in the body it will be most beneficial and the occurrence of unwanted side effects due the drug are significantly minimized. | 10-15-2009 |
20090281473 | Anti-Human Immunodeficiency Virus Surrogate Target Agent Technology Filter Intended to Neutralize or Remove Human Immunodeficiency Virus Virions From Blood - The Human Immunodeficiency Virus posses a significant threat to the world's population. Current strategies utilized to treat infectious agents have not been adequate to contain and eradicate this deadly viral infection. HIV seeks out its host, a T-Helper cell, by utilizing glycoprotein 120 probes to engage a CD4 cell-surface receptor located on the surface of a T-Helper cell. Developing blood filtering techniques that incorporate filter mediums that offer HIV virion's probes the opportunity to engage the cell-surface receptors they are seeking offers a means of neutralizing and removing HIV. Filtering the blood of a patient with filter mediums comprised of T-Helper cells, sheets of lipid bilayer or virus-like structures with each type of medium possessing cell-surface receptors intended to attract and engage HIV virions provides an effective strategy to prevent and treat AIDS. | 11-12-2009 |
20090291118 | UNIVERSAL BARRIER TO PREVENT INFECTIONS FROM HUMAN IMMUNODEFICIENCY VIRUS - The Human Immunodeficiency Virus poses a significant threat to the world's population. Current strategies to treat infectious agents have not been adequate to eradicate such deadly viral infections. HIV seeks out its host, a T-Helper cell, by utilizing glycoprotein 120 probes to engage a CD4 cell-surface receptor located on the surface of a T-Helper cell. Developing devices to offer HIV virions' probes the opportunity to engage the cell-surface receptors they are seeking offers a means of neutralizing the infectious threat of HIV. A device in the form of a solution containing a filter medium comprised of sheets or strips or spheres of lipid bilayer or virus-like structures or hypoallergenic surfaces to carry cell-surface receptors, each type of medium having affixed to its surface cell-surface receptors intended to engage and neutralize the infectious nature of HIV virions provides an effective strategy to avert AIDS. | 11-26-2009 |
20090297484 | METHOD FOR CURING AND PREVENTING ACQUIRED IMMUNE DEFICIENCY SYNDROME BY ALTERING CELL-SURFACE RECEPTORS IN PRECURSOR T-HELPER CELLS AND MATURE T-HELPER CELLS TO PREVENT HUMAN IMMUNODEFICIENCY VIRUS VIRIONS ACCESS TO MATURE HELPER CELLS - The medical method by which a modified Human Immunodeficiency Virus or virus-like structure is used as a transport medium to carry a medically therapeutic ribonucleic acid to precursor T-Helper cells and mature T-Helper cells to prevent AIDS. The modified Human Immunodeficiency Virus or virus-like structures make contact with precursor T-Helper cells or mature T-Helper cells by means exterior probes. Once the exterior probes engage the precursor T-Helper cells' or mature T-Helper cells' cell-surface receptors, the modified virus or virus-like structures inserts into the cells the medically therapeutic ribonucleic acid they are carrying. The medically therapeutic ribonucleic acid causes T-Helper cells to express an altered cell-surface receptor on their surface thus thwarting HIV virions from being able to gain access to such cells, thus preventing AIDS. | 12-03-2009 |
20110064790 | ADAPTABLE MODIFIED VIRUS VECTOR TO DELIVER RIBOSOMAL RIBONUCLEIC ACID AS A MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS AND OTHER PROTEIN DEFICIENT DISEASES - Diabetes mellitus is a disease of elevated blood glucose, often directly related to a deficiency in insulin production or insulin receptor production. The innovative strategy of treatment described here utilizes modified viruses and virus-like vehicles to act as a transport mechanism to deliver ribosomal RNA molecules to target cells in the body. Delivering to the Beta cells in the body the ribosomal RNA needed to assist ribosomes with the construction of insulin or insulin receptors will lead to enhanced production of biologically active insulin or insulin receptors by Beta cells as necessary, which will lead to correcting deficiencies in insulin or insulin receptors, the result of which will help properly regulate blood glucose levels throughout the body utilizing innate cellular regulatory mechanisms. | 03-17-2011 |
20110070289 | ADAPTABLE MODIFIED VIRUS VECTOR TO DELIVER MODIFIED MESSENGER RIBONUCLEIC ACID AS A MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS AND OTHER PROTEIN DEFICIENT DISEASES - Diabetes mellitus is a disease of elevated blood glucose, often directly related to a deficiency in insulin production or insulin receptor production. The innovative strategy of treatment described here utilizes modified viruses and virus-like vehicles to act as a transport mechanism to deliver modified messenger RNA molecules to target cells in the body. Delivering to the Beta cells in the body the modified messenger RNA needed to construction of insulin or insulin receptors will lead to enhanced production of biologically active insulin or insulin receptors by Beta cells as necessary, which will lead to correcting deficiencies in insulin or insulin receptors the result of which will help properly regulate blood glucose levels throughout the body utilizing innate regulatory mechanisms. | 03-24-2011 |
20110212160 | CONFIGURABLE MICROSCOPIC MEDICAL PAYLOAD DELIVERY DEVICE TO DELIVER NUCLEAR SIGNALING PROTEINS TO SPECIFIC CELLS TO MANAGE DIABETES MELLITUS AND GENETIC DEFICIENCY DISORDERS - The innovative treatment strategy described here utilizes configurable microscopic medical payload delivery devices to act as a transport vector to deliver nuclear signaling proteins to specific cell types in the body. Utilizing probes on the exterior of the transport device, transport device locate specific target cell types in the body. Once a specific target cell type has been encountered, the configurable microscopic medical payload delivery device inserts its payload of nuclear signaling proteins into the target cell type. By delivering nuclear signaling proteins to specific cell types, genes can be activated or inactivated in those specific cell types. These medically therapeutic nuclear signaling proteins are intended to improve cell function or the longevity of the cell or eliminate cells that pose a hazard to the general health of the body. | 09-01-2011 |
20110212177 | CONFIGURABLE MICROSCOPIC MEDICAL PAYLOAD DELIVERY DEVICE TO DELIVER MEDICALLY THERAPEUTIC PAYLOADS TO SPECIFICALLY TARGETED CELL TYPES - The innovative strategy of treatment described here utilizes configurable microscopic medical payload delivery devices to act as a transport mechanism to deliver medically therapeutic payloads to specific cell types in the body. Utilizing probes on the exterior of the configurable microscopic medical payload delivery devices, these transport devices locate specific types of target cells in the body. Once a specific target cell is encountered and engaged, the configurable microscopic medical payload delivery device inserts its payload into the target cell. These medically therapeutic payloads are intended to improve cell function or the longevity of the cell or eliminate cells that pose a hazard to the general health of the body. By utilizing configurable microscopic medical payload delivery devices as a delivery system, the efficacy of medications and biologic tools are dramatically improved and there is a resultant significant reduction in the occurrence of unwanted side effects. | 09-01-2011 |
20110236466 | CHEMO VECTOR THERAPY TO DELIVER CHEMOTHERAPY MOLECULES TO SPECIFIC CELLS TO MANAGE BREAST CANCER, OTHER CANCERS AND INFLAMMATORY DISORDERS - The innovative treatment strategy described here utilizes configurable microscopic medical payload delivery devices to act as a transport means to deliver chemotherapy molecules to specific cell types in the body. Utilizing probes present on the exterior of the transport device, transport device locates specific target cell types in the body. Once a specific target cell type has been encountered, the configurable microscopic medical payload delivery device inserts its payload of chemotherapy molecules into the target cell type. By delivering chemotherapy molecules into specific cells, the growth of the specific cells can be stifled. Delivering chemotherapy molecules into specific cancer cells inhibits the rate of growth and rate of cell reproduction of the cancer cells. Utilizing configurable microscopic medical payload delivery devices to insert chemotherapy into targeted cancer cells or inflammatory cells effectively manages cancer, inflammatory arthritis and other inflammatory conditions, while preventing unwanted side effects. | 09-29-2011 |
20110236483 | RNA VECTOR THERAPY - The innovative treatment strategy described here utilizes configurable microscopic medical payload delivery devices to act as a transport vector to deliver a wide variety of cellular ribonucleic acid molecules to specific types of cells in the body. Utilizing probes on the exterior of the transport devices, the transport devices locate a specific type of cell in the body. Once a specific target cell type has been encountered, the configurable microscopic medical payload delivery devices insert their payload of cellular ribonucleic acid molecules into the target cells. By delivering cellular ribonucleic acid molecules into specific cells a wide variety of protein deficiencies are correctable, gene expression is capable of being modulated, and telomere synthesis is enhanced. | 09-29-2011 |
20110237653 | RNA VECTOR THERAPY METHOD - The innovative treatment method described here utilizes configurable microscopic medical payload delivery devices to act as a transport vector to deliver a wide variety of cellular ribonucleic acid molecules to specific types of cells in the body. Utilizing probes on the exterior of the transport devices, the transport devices locate a specific type of cell in the body. Once a specific target cell type has been encountered, the configurable microscopic medical payload delivery devices insert their payload of cellular ribonucleic acid molecules into the target cells. By delivering cellular ribonucleic acid molecules into specific cells a wide variety of protein deficiencies are correctable, gene expression is capable of being modulated, and telomere synthesis is enhanced. | 09-29-2011 |
20110293693 | QUANTUM UNIT OF INHERITANCE VECTOR THERAPY - The innovative treatment strategy described here utilizes configurable microscopic medical payload delivery devices to act as a transport vector to deliver quantum genes to specific type of cells in the body. Utilizing probes on the exterior of the transport device, transport device locate specific target cell types in the body. Once a specific target cell type has been encountered, the configurable microscopic medical payload delivery device inserts its payload of quantum genes into the target cell type. By delivering quantum genes to specific type of cells, genes can be activated or inactivated in those specific type of cells. These medically therapeutic quantum genes are intended to improve cell function or the longevity of cells or neutralize harmful cells that pose a hazard to the general health of the body. | 12-01-2011 |
20110293694 | QUANTUM UNIT OF INHERITANCE VECTOR THERAPY METHOD - The innovative treatment method described here utilizes configurable microscopic medical payload delivery devices to act as a transport vector to deliver quantum genes to specific type of cells in the body. Utilizing probes on the exterior of the transport device, transport device locate specific target cell types in the body. Once a specific target cell type has been encountered, the configurable microscopic medical payload delivery device inserts its payload of quantum genes into the target cell type. By delivering quantum genes to specific type of cells, genes can be activated or inactivated in those specific type of cells. This method of delivering medically therapeutic quantum genes to specific cells is intended to improve cell function or extend the longevity of cells or neutralize harmful cells that pose a hazard to the body. | 12-01-2011 |
20110294996 | QUANTUM UNIT OF INHERITANCE - Quantum genes have a unique identifier assigned to them. By identifying genetic material with a unique identifier a means of locating specific genetic material is plausible. Delivering such quantum genes, that contain a unique identifier, to specific cell types provides a means of inserting specific genetic information into the cell's nuclear deoxyribonucleic acid that can be readily located by the cell's nuclear transcription complexes. These medically therapeutic quantum genes are intended to provide a wide variety of medical therapeutic options to clinicians. | 12-01-2011 |